Literature DB >> 1711539

T cell sensitization to proteolipid protein in myelin basic protein-induced relapsing experimental allergic encephalomyelitis.

L L Perry1, E Barzaga-Gilbert, J L Trotter.   

Abstract

(SJL/J x PL/J)F1 mice immunized with myelin basic protein (MBP) develop an autoimmune demyelinating disease termed relapsing experimental allergic encephalomyelitis (rEAE). The acute state of disease is mediated by CD4+ T cells specific for MBP amino acids 1-9. To determine the immunologic bases for disease relapse, host sensitization to additional autoantigens of the central nervous system was measured. Results indicate that most animals develop T cell reactivity to endogenous myelin proteolipid protein (PLP) during rEAE. However, PLP-specific immunity does not appear to account for expression of relapse episodes of demyelination.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1711539      PMCID: PMC7172317          DOI: 10.1016/0165-5728(91)90029-7

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  62 in total

1.  Mechanisms in multiple sclerosis.

Authors:  B Waksman
Journal:  Nature       Date:  1985 Nov 14-20       Impact factor: 49.962

2.  Modulation of experimental allergic encephalomyelitis with anti-T suppressor factor antibodies.

Authors:  L L Perry; M E Barzaga; T A Ferguson
Journal:  J Immunol       Date:  1988-11-01       Impact factor: 5.422

3.  Cell-mediated immunity to myelin-associated glycoprotein, proteolipid protein, and myelin basic protein in multiple sclerosis.

Authors:  D Johnson; D A Hafler; R J Fallis; M B Lees; R O Brady; R H Quarles; H L Weiner
Journal:  J Neuroimmunol       Date:  1986-11       Impact factor: 3.478

4.  A radioimmunoassay for myelin basic protein and its use for quantitative measurements.

Authors:  S R Cohen; G M McKhann; M Guarnieri
Journal:  J Neurochem       Date:  1975-10       Impact factor: 5.372

5.  Viral specificity of multiple sclerosis tear immunoglobulins.

Authors:  P K Coyle; P A Sibony
Journal:  J Neuroimmunol       Date:  1987-03       Impact factor: 3.478

6.  Fine specificity and HLA restriction of myelin basic protein-specific cytotoxic T cell lines from multiple sclerosis patients and healthy individuals.

Authors:  R Martin; D Jaraquemada; M Flerlage; J Richert; J Whitaker; E O Long; D E McFarlin; H F McFarland
Journal:  J Immunol       Date:  1990-07-15       Impact factor: 5.422

7.  Antibodies against the paramyxovirus SV5 in the cerebrospinal fluids of some multiple sclerosis patients.

Authors:  K K Goswami; R E Randall; L S Lange; W C Russell
Journal:  Nature       Date:  1987 May 21-27       Impact factor: 49.962

8.  Purification of proteolipid protein and production of specific antiserum.

Authors:  D R Hampson; S E Poduslo
Journal:  J Neuroimmunol       Date:  1986-04       Impact factor: 3.478

9.  Encephalitogenic activity of guinea pig myelin basic protein in the SJL mouse.

Authors:  C B Pettinelli; R B Fritz; C H Chou; D E McFarlin
Journal:  J Immunol       Date:  1982-09       Impact factor: 5.422

10.  Multiple discrete encephalitogenic epitopes of the autoantigen myelin basic protein include a determinant for I-E class II-restricted T cells.

Authors:  S S Zamvil; D J Mitchell; M B Powell; K Sakai; J B Rothbard; L Steinman
Journal:  J Exp Med       Date:  1988-09-01       Impact factor: 14.307

View more
  12 in total

1.  Diversity and plasticity of self recognition during the development of multiple sclerosis.

Authors:  V K Tuohy; M Yu; B Weinstock-Guttman; R P Kinkel
Journal:  J Clin Invest       Date:  1997-04-01       Impact factor: 14.808

2.  Reactivity to myelin antigens in multiple sclerosis. Peripheral blood lymphocytes respond predominantly to myelin oligodendrocyte glycoprotein.

Authors:  N Kerlero de Rosbo; R Milo; M B Lees; D Burger; C C Bernard; A Ben-Nun
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

3.  Treatment of experimental encephalomyelitis with a novel chimeric fusion protein of myelin basic protein and proteolipid protein.

Authors:  E A Elliott; H I McFarland; S H Nye; R Cofiell; T M Wilson; J A Wilkins; S P Squinto; L A Matis; J P Mueller
Journal:  J Clin Invest       Date:  1996-10-01       Impact factor: 14.808

4.  Myelin basic protein-specific T lymphocyte repertoire in multiple sclerosis. Complexity of the response and dominance of nested epitopes due to recruitment of multiple T cell clones.

Authors:  E Meinl; F Weber; K Drexler; C Morelle; M Ott; G Saruhan-Direskeneli; N Goebels; B Ertl; G Jechart; G Giegerich
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

5.  Multiantigen/multiepitope-directed immune-specific suppression of "complex autoimmune encephalomyelitis" by a novel protein product of a synthetic gene.

Authors:  Ming-Chao Zhong; Nicole Kerlero de Rosbo; Avraham Ben-Nun
Journal:  J Clin Invest       Date:  2002-07       Impact factor: 14.808

6.  Suppression of MOG- and PLP-induced experimental autoimmune encephalomyelitis using a novel multivalent bifunctional peptide inhibitor.

Authors:  Ahmed H Badawi; Teruna J Siahaan
Journal:  J Neuroimmunol       Date:  2013-08-01       Impact factor: 3.478

7.  Long-term inhibition of murine experimental autoimmune encephalomyelitis using CTLA-4-Fc supports a key role for CD28 costimulation.

Authors:  A H Cross; T J Girard; K S Giacoletto; R J Evans; R M Keeling; R F Lin; J L Trotter; R W Karr
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

Review 8.  Peptide determinants of myelin proteolipid protein (PLP) in autoimmune demyelinating disease: a review.

Authors:  V K Tuohy
Journal:  Neurochem Res       Date:  1994-08       Impact factor: 3.996

9.  A predictable sequential determinant spreading cascade invariably accompanies progression of experimental autoimmune encephalomyelitis: a basis for peptide-specific therapy after onset of clinical disease.

Authors:  M Yu; J M Johnson; V K Tuohy
Journal:  J Exp Med       Date:  1996-04-01       Impact factor: 14.307

10.  Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis.

Authors:  B L McRae; C L Vanderlugt; M C Dal Canto; S D Miller
Journal:  J Exp Med       Date:  1995-07-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.